May 08, 2019 - Aduro (ADRO) suspends the BION-1301 program for MM in Q1 due to severe competition.
May 07, 2019 - The focus will be on Nektar Therapeutics' (NKTR) pipeline progress when the company reports first-quarter results.
May 07, 2019 - Bausch (BHC) Q1 earnings surpass estimates, while revenues miss the same. The increase in guidance was impressive.
May 03, 2019 - Barclays issues rating change for BMY
May 02, 2019 - Exelixis's (EXEL) earnings and revenues beat expectations in the first quarter on strong sales of Cabometyx.
May 01, 2019 - Top Research Reports for ExxonMobil, Morgan Stanley & Bristol-Myers
Apr 29, 2019 - They could be big winners for patient investors.
Apr 28, 2019 - So far, the going seems good for the drug/biotech sector this earnings season. Let us take a glance at a few other companies, which hold promise to beat on Q1 earnings.
Apr 26, 2019 - Celgene (CELG) beats on earnings and sales in the first quarter of 2019.
Apr 25, 2019 - Bristol-Myers Squibb Company (NYSE:BMY) Q1 2019 Earnings Conference Call April 25, 2019 10:30 AM ET Company Participants John Elicker - Senior Vice President, Public Affairs & Investor Relations G